Eye Care News ~

Eye Care News — ScienceDaily Learn about glaucoma symptoms and cataracts, as well as laser eye surgery and optic nerve regeneration. Read the latest medical research on diagnosis and new treatment options.

Another reason to get cataract surgery: It can make you 48% safer on the road
on October 12, 2019 at 6:12 pm
Researchers in Australia used a driving simulator to test patients’ vision before and after cataract surgery. They found that near misses and crashes decreased by 48% after surgery.
More evidence linking common bladder medication to a vision-threatening eye condition
on October 12, 2019 at 6:12 pm
A drug widely prescribed for a bladder condition for decades, now appears to be toxic to the retina, the light sensing tissue at the back of the eye that allows us to see.
In-office gene therapy for wet age-related macular degeneration is coming
on October 11, 2019 at 11:47 am
Gene therapy is showing promise for one of the most common causes of blindness.
A timekeeper for siesta
on October 7, 2019 at 2:36 pm
External stimuli can rearrange the hierarchy of neuronal networks and influence behavior. This was demonstrated by scientists using the circadian clock of the fruit fly as an example.
Optical imager poised to improve diagnosis and treatment of dry eye disease
on October 4, 2019 at 7:52 pm
Researchers have developed a new non-invasive optical imaging system that promises to improve diagnosis and treatments for dry eye disease. Dry eye, which often causes irritation and blurred vision, occurs when there is instability in the inner layer of the tear film that protects the outside of the eye.

Women, younger patients most likely to heed follow-up advice
on October 10, 2019 at 12:00 pm
Investigators identified patient characteristics associated with follow-up compliance after cataract surgery.
Hydrus microstent shows promising efficacy at 2 years
on October 9, 2019 at 1:00 pm
Investigators assessed the safety and efficacy of Schlemm canal stenting in combination with cataract surgery in eyes with mild to moderate primary open-angle glaucoma (POAG).
Brolucizumab wins FDA approval, introducing extended dosing for wet AMD
on October 9, 2019 at 11:00 am
Novartis’ brolucizumab (Beovu) is now FDA approved for the treatment of wet AMD, the company reported today.
Lamotrigine can lead to remission of visual snow symptoms
on October 8, 2019 at 4:00 am
Researchers evaluated pharmacologic treatment options for visual snow and reported the prevalence of comorbid diseases.
Adolescent keratoconus patients should be monitored for progression after CXL
on October 7, 2019 at 1:00 pm
Investigators report the long-term results of accelerated corneal collagen crosslinking (CXL) treatment in adolescent patients with progressive keratoconus.